It was reported that glioma initiating CD133(+) cells and Mφs/microglia cointeraction activated expression of B7-H4 via IL6-activated STAT3, thereby blocking effective T-cell immune responses within the microenvironment of gliomas (42). The gene discussed is VTCN1; the disease is central nervous system cancer.